Are pulmonary bullae classified as cysts or blebs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bullae Are Neither Cysts Nor Blebs—They Are Distinct Entities

Bullae, blebs, and cysts are three separate pathological entities with distinct definitions based on size, location, and wall characteristics. Understanding these differences is critical for accurate diagnosis and appropriate management, particularly in the context of pneumothorax risk assessment.

Key Definitions

Bullae

  • Air-filled spaces measuring >1-2 cm in diameter 1
  • Sharply demarcated by a thin wall 2
  • Can occur anywhere in the lung parenchyma
  • Associated with emphysematous changes and parenchymal destruction
  • Wall thickness ≤4 mm 3

Blebs

  • Smaller subpleural air collections, typically <1-2 cm 1
  • Located specifically in the subpleural space
  • Found in up to 90% of primary spontaneous pneumothorax cases at thoracoscopy 4
  • The terms "blebs" and "bullae" are often used interchangeably in surgical literature, though they represent different size categories 1

Cysts

  • Air-filled spaces with wall thickness ≤4 mm 3
  • Can have various etiologies (congenital, infectious, neoplastic)
  • Distinguished from bullae by clinical context and associated findings
  • May change size with respiration (bronchiectatic cysts enlarge on inspiration, while bullae do not) 5

Clinical Distinction Algorithm

When evaluating air-filled lung lesions:

  1. Measure the lesion size:

    • <1-2 cm → Consider bleb (especially if subpleural)
    • ≥1-2 cm → Consider bulla or cyst
  2. Assess wall thickness:

    • ≤4 mm → Cyst or bulla
    • 4 mm or surrounding infiltrate/mass → Cavity (different entity) 3

  3. Evaluate location:

    • Subpleural, apical → Bleb more likely
    • Parenchymal, lower zones → Bulla (especially in emphysema/AAT deficiency) 2
  4. Consider dynamic changes:

    • Changes size with respiration → Bronchiectatic cyst 5
    • No size change → Bulla 5
  5. Assess clinical context:

    • Emphysema, smoking history → Bullae 4, 2
    • Young, healthy patient with pneumothorax → Blebs 4
    • Complex disease (LAM, LCH, fibrosis) → True cysts 3

Critical Clinical Implications

CT imaging is essential when differentiating bullae from pneumothorax in complex bullous lung disease 4, as this distinction prevents unnecessary and potentially dangerous interventions.

Common Pitfall

The most dangerous error is attempting aspiration of a bulla mistaken for a pneumothorax in patients with severe bullous disease—CT scanning should be performed first to avoid this complication 4.

Pneumothorax Risk

  • Blebs and bullae are found in up to 90% of primary spontaneous pneumothorax cases 4
  • However, incidentally found bullae/blebs do not necessarily require prophylactic intervention 6, 7
  • Surgical intervention is reserved for specific indications (recurrent pneumothorax, persistent air leak, high-risk occupations) 1

Practical Management Considerations

The distinction matters most when:

  • Differentiating pneumothorax from bullous disease on imaging 4
  • Planning surgical intervention (bullectomy targets bullae >1-2 cm) 1
  • Assessing pneumothorax risk in patients with incidental findings 6, 7
  • Determining appropriate follow-up imaging strategies

The terminology overlap in clinical practice (particularly "blebs and bullae" used interchangeably) 1 can create confusion, but the size-based distinction (1-2 cm cutoff) and location (subpleural vs. parenchymal) provide the most clinically useful framework for classification and management decisions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.